Keyword: Johnson & Johnson
News
04.04.2017
- Based on interim results of its $280 per share tender offer for all publicly held shares of Swiss biopharmaceuticals company Actelion, US healthcare giant Johnson & Johnson has...
News
13.03.2017
- US healthcare giant Johnson & Johnson (J&J) has announced plans to close its surgical suture manufacturing plant in Livingston, Scotland, with the potential loss of 400 jobs...
News
08.03.2017
- After losing three earlier lawsuits alleging that its talc powder caused ovarian cancer – which cost it nearly $200 million in damages – US healthcare giant Johnson & Johnson (J&J)...
News
01.02.2017
- In a meeting at the White House on Jan. 31, new US president, Donald Trump, held out both a carrot and a stick to pharmaceutical producers. The industry will “have to “get prices...
News
27.01.2017
- Johnson & Johnson (J&J) has won its battle to acquire Swiss biotechnology firm Actelion. The deal announced on Jan. 26 foresees the New Jersey, USA-based healthcare company...
News
13.01.2017
- American drugmakers, who had hoped US President-Elect Donald Trump would go easier on the industry than Hillary Clinton and Bernie Sanders had promised to do, received an...
News
09.01.2017
- Actelion and Johnson & Johnson may be edging closer to a deal that would give the US healthcare giant at least a major chunk of the Swiss biotech firm, according to the Zurich...
News
29.12.2016
- US healthcare company Johnson & Johnson (J&J) is negotiating a deal to acquire Actelion that would see its commercial portfolio separated from its R&D assets, according to news...
